Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients.

Wells CW, Lewis S, Barton JR, Corbett S.

Inflamm Bowel Dis. 2006 Feb;12(2):123-30.

PMID:
16432377
2.

Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.

Gisbert JP, Bermejo F, Pajares R, Pérez-Calle JL, Rodríguez M, Algaba A, Mancenido N, de la Morena F, Carneros JA, McNicholl AG, González-Lama Y, Maté J.

Inflamm Bowel Dis. 2009 Oct;15(10):1485-91. doi: 10.1002/ibd.20925.

PMID:
19408339
3.

Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.

Gisbert JP, Gomollón F.

Am J Gastroenterol. 2008 May;103(5):1299-307. doi: 10.1111/j.1572-0241.2008.01846.x. Review.

PMID:
18477354
4.

A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.

Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C.

Am J Gastroenterol. 2008 May;103(5):1182-92. doi: 10.1111/j.1572-0241.2007.01744.x. Epub 2008 Mar 26.

PMID:
18371137
5.

Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.

Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasché C, Lochs H, Raedler A.

N Engl J Med. 1996 Mar 7;334(10):619-23.

6.

Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.

Voudoukis E, Karmiris K, Oustamanolakis P, Theodoropoulou A, Sfiridaki A, Paspatis GA, Koutroubakis IE.

Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1212-6. doi: 10.1097/MEG.0b013e328363e354.

PMID:
23839158
7.

Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.

Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mittermaier C, Petritsch W; Austrian Inflammatory Bowel Diseases Study Group.

Am J Gastroenterol. 2001 Aug;96(8):2382-7.

PMID:
11513178
8.

Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease.

Koutroubakis IE, Oustamanolakis P, Karakoidas C, Mantzaris GJ, Kouroumalis EA.

Dig Dis Sci. 2010 Aug;55(8):2327-31. doi: 10.1007/s10620-009-1022-y. Epub 2009 Oct 16.

PMID:
19834803
9.

Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.

Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R, Weinstock JV.

Am J Gastroenterol. 2003 Sep;98(9):2034-41.

PMID:
14499784
10.

Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

Toblli JE, Lombraña A, Duarte P, Di Gennaro F.

J Am Coll Cardiol. 2007 Oct 23;50(17):1657-65.

11.

[Pathophysiological-based diagnosis and therapy of iron-deficient anaemia in inflammatory bowel disease].

Stein JM, Hartmann F, Cordes HJ, Dignass AU.

Z Gastroenterol. 2009 Feb;47(2):228-36. doi: 10.1055/s-2008-1027876. Epub 2009 Feb 5. Review. German.

PMID:
19197827
12.

Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease.

Goodhand JR, Kamperidis N, Rao A, Laskaratos F, McDermott A, Wahed M, Naik S, Croft NM, Lindsay JO, Sanderson IR, Rampton DS.

Inflamm Bowel Dis. 2012 Mar;18(3):513-9. doi: 10.1002/ibd.21740. Epub 2011 May 20.

PMID:
21604328
13.

[Risk of development of clinical and pathogenetic features of anemia on the background of basic therapy of inflammatory bowel disease].

Noskova KK, Lishchinskaia AA, Parfenov AI, Kniazev OV, Varvanina GG, Drozdov VN.

Eksp Klin Gastroenterol. 2011;(10):12-7. Russian.

PMID:
22629693
14.

Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.

Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.

Am Heart J. 2006 Dec;152(6):1096.e9-15.

PMID:
17161060
15.

The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia.

Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, Dahlerup JF.

Scand J Gastroenterol. 2011 Mar;46(3):304-9. doi: 10.3109/00365521.2010.533382. Epub 2010 Nov 15.

PMID:
21073374
16.

Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, Tillinger W, Gangl A, Moser G.

Psychosom Med. 2004 Jan-Feb;66(1):79-84.

PMID:
14747641
17.

Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.

Song CS, Park DI, Yoon MY, Seok HS, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI.

Dig Dis Sci. 2012 Apr;57(4):1033-8. doi: 10.1007/s10620-011-1978-2. Epub 2011 Dec 7.

PMID:
22147246
18.

The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.

Clara I, Lix LM, Walker JR, Graff LA, Miller N, Rogala L, Rawsthorne P, Bernstein CN.

Am J Gastroenterol. 2009 Jul;104(7):1754-63. doi: 10.1038/ajg.2009.197. Epub 2009 May 19.

PMID:
19455122
19.
20.

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A.

J Am Coll Cardiol. 2000 Jun;35(7):1737-44.

Supplemental Content

Support Center